Participant in Covid vaccine trial sent legal notice to Serum Institute, claiming neurological & psychological symptoms, seeking Rs 5 crore in compensation.
Poonawalla, CEO of the Serum Institute of India, disclosed that the pharma giant will apply for emergency authorisation of the Covid-19 vaccine in the next 2 weeks.
Chennai-based participant also sends legal notice to ICMR, DCGI, AstraZeneca & Oxford University to stop testing, manufacturing & distributing vaccine.
The comments came after AstraZeneca & Oxford University acknowledged a manufacturing error that is raising doubts about preliminary results of their experimental Covid-19 vaccine.
Earlier this month, the Serum Institute of India had paused the clinical trials of Oxford vaccine candidate in India. On 15 September, the DCGI gave permission to resume the trial.
The latest additions to ThePrint’s properties will improve your understanding of the India we live in, whether it's through the prism of AI or civil services.
SEBI probe concluded that purported loans and fund transfers were paid back in full and did not amount to deceptive market practices or unreported related party transactions.
Since 1815, Nepali Gorkhas have served in Indian & British Armies, as well as in Bihar, Bengal & Assam Police. Since Agnipath scheme came in, no Nepal-domiciled Gorkha has enlisted.
What Munir has achieved with Trump is a return to normal, ironing out the post-Abbottabad crease. The White House picture gives us insight into how Pakistan survives, occasionally thrives and thinks.
COMMENTS